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Abstract 
Chronic kidney disease is the progressive loss of kidney function over months or years. The 
significant increase in new cases of chronic kidney disease is in line with the increasing number 
of patients undergoing hemodialysis as kidney replacement therapy in an effort to survive. 
Comorbid cardiovascular disease is a major risk factor for morbidity and mortality with chronic 
kidney disease. The study was conducted to determine the survival of hemodialysis patients in 
the group with comorbid cardiovascular disease and the group without comorbid cardiovascular 
disease. This study used a retrospective cohort design. The location of this study was conducted 
at Persahabatan Central Public Hospital, DKI Jakarta, and used secondary data from the hospital 
information system data from 2015 to 2019. The variables significantly related to the survival of 
patients undergoing hemodialysis with comorbid cardiovascular disease were age, 
complications of anemia, diabetes mellitus, and hypertension. The age variable has a p-value of 
0.029 with an HR of 1.54 (95% CI OR 1.043-2.262). The anemia variable has a p-value of 
0.013 with an HR of 1.60 (95% CI 1.117-2.515). The diabetes mellitus variable has a p-value of 
0.000 with HR2.71 (95% CI 1.780-4.11). The hypertension variable has a p-value of 0.004 with 
HR1.79 (95% CI 1.208-2.646). In conclusion, patients undergoing hemodialysis with comorbid 
cardiovascular disease have a risk of death of 0.76 times compared to patients undergoing 
hemodialysis with the comorbid non-cardiovascular disease. This study's internal validity was 
not good due to selection bias and non-differential misclassification information bias. Thus, the 
results of this study cannot be generalized. 
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Chronic kidney disease is the progressive loss of kidney function over months or 
years ( World Kidney Day, 2020). Chronic kidney disease initially does not show signs 
and symptoms but it can progress to kidney failure (World Kidney Day, 2019). The 
global prevalence of chronic kidney disease in 2017 was 697.5 million cases (95% CI 
649.2-752.0 million) (Bikbov, et al., 2020). According to WHO, worldwide chronic 
kidney disease currently affects 8%-16% of the world's population (Chen, et al., 2019). 
In 2017, the Southeast Asia region was ranked 3rd in the world with a prevalence of 
69.6 million cases of chronic kidney disease (95%CI 64.2-75.1 million). Indonesia has 
more than 10 million cases of chronic kidney disease, with a total of 27.2 million cases 
(Bikbov, et al., 2020). Every year, the number of patients with kidney disease is 
increasing. Based on Riskesdas 2018, the number of sufferers of chronic kidney disease 
(CKD) in Indonesia rose from 2.0 per mile in 2013 to 3.8 per mile in 2018 
(Kementerian Kesehatan Republik Indonesia, 2018). 
Chronic kidney disease is divided into 5 stages in which the last stage is the worst 
stage. At that stage, the kidneys are no longer functioning optimally so they require 
renal replacement therapy. One of the most common types of kidney replacement 
therapy performed by patients with chronic kidney disease is 99% hemodialysis in 2018 
(Indonesian Renal Registry, 2018). Chronic kidney disease causes at least 2.4 million 
deaths per year and is now the sixth leading cause of death (World Kidney Day, 2019). 
According to research conducted by (Bikbov, et al., 2020), the mortality of chronic 
kidney disease in the world in 2017 was 1.2 million deaths (95% CI 1.2-1.3 million) 
while Southeast Asia was ranked 3rd in the world with the number of deaths from 
chronic kidney disease of 134,459 deaths. Indonesia in 2017 amounted to 35,466 deaths 
(Bikbov, et al., 2020). 
Approximately, 91% of patients who started hemodialysis under the age of 70 
years were still alive after 12 months of treatment (Prasad, & Jha, 2015). In Indonesia, 
the survival study of patients with chronic kidney disease (CKD) with HD in general 
was 67.84 months at the Soetomo Public Hospital (Yulianto, & Basuki, 2017). Based on 
the calculations that have been performed, it is known that the survival of patients with 
kidney failure undergoing hemodialysis is 776 days (Habibah, et al., 2018). One-, two- 
and three-year survival of patients are 82%, 13% and 10%, respectively. Cardiovascular 
events are the main cause of death in patients (22.72%) (Msaad, et al., 2019). The most 
common cause of death in hemodialysis patients is cardiovascular (K1) as much as 42% 
(Indonesian Renal Registry, 2018). The cause of death among hemodialysis patients 
2011-2013 is arrhythmia/cardiac arrest of 28%, other cardiovascular diseases of 12.4%. 
Patients who are female, and have a history of hypertension, diabetes mellitus and the 
presence of complications of anemia have a lower average survival (Yulianto, & 
Basuki, 2017). Patients on hemodialysis with hemoglobin levels <10 g/dL had an 
increased risk of cardiovascular death, 2.24 (95% CI, 1.40–3.59) in patients with 
hemoglobin levels <9 mg/dL (Kuo, et al., 2018). 
Chronic kidney disease is still a major health problem in Indonesia, which is 
associated with a high mortality rate. Comorbidities are the dominant factors that 
influence the survival of chronic kidney disease patients undergoing hemodialysis. 
Through this retrospective cohort study, researchers determined the survival of 
hemodialysis patients in the group with comorbid cardiovascular disease and the group 
without comorbid cardiovascular disease at Persahabatan Central Public 
Hospital,Jakarta in 2015-2019. The benefits of this study are expected to provide 
information about the description of the survival rate of hemodialysis patients based on 
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the presence or absence of comorbid cardiovascular disease and provide information 
about the effect of comorbid cardiovascular disease and other variables on the survival 
of hemodialysis patients so that the community can make prevention efforts by 
controlling these factors. 
 
2. RESEARCH METHOD 
This study is an observational analytic epidemiological study with a retrospective 
cohort study. Observations were conducted within a certain period of time from 
exposure to events (deaths) that had occurred in the past or before the researcher started 
the study. Data collection was performed using medical record data in the information 
system from 2015-2019. The population in the study were patients undergoing 
hemodialysis at Persahabatan Central Public Hospital. The samples were patients from 
2015 to 2019 who had met the inclusion criteria. The inclusion criteria were new 
patients undergoing hemodialysis at the Persahabatan Central Public Hospital. In this 
study, the sample used was 290 patients who met the inclusion and exclusion criteria. 
The inclusion criteria in this study were that the patient was a new case of chronic 
kidney disease diagnosed during January 2015 to November 2019 and only underwent 
hemodialysis at Persahabatan Central Public Hospital in Jakarta. The exclusion criteria 
in this study were patients whose medical records were incomplete. 
The data obtained was then administered editing, coding, data entry, and data 
cleaning. This study employed univariate, bivariate, and multivariate analysis with 
Kaplan meir analysis, log rank and cox regression with 95% confidence level. In this 
study, the dependent variable was survival, the independent variable was comorbid 
cardiovascular disease and the covariates were age, sex, hypertension, diabetes mellitus 
and anemia complications. This article has received ethical approval from the Ethics 
Commission of the University of Indonesia with ethical no: 
356/UN2.F10.D11/PPM.00.02/2021. 
 
3. RESULTS AND DISCUSSION 
 
Table 1. Characteristics of Patients Undergoing Hemodialysis at Persahabatan Central 
Public Hospital 2015-2019. 











    
Sensor  68  36,36  119     63,64  187 64,48 
Event  42  40,78    61     59,22  103   35,52 
Age 
(average±sd) 
55,4±15,3  54,3±11.4    
< 60  53  31,74  114     68,26  167 58,92 
 ≥ 60  57  46,34    66     53,66  123   41,03 
Gender       
Male 60  36,14  106     63,86  166 57,24 
Female 50  40,32    74     59,68  124   42,76 
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Anemia       
No 75  36,95  128     63,05  203 70,24 
yes 35  40,23  52     59,77  87   29,76 
DM       
No 81  36,99  138     63,01  219 75,52 
Yes 29  40,85    42     59,15  71   24,48 
Hypertension       
No 63  36,42  110     63,58  173 59,66 
Yes 47  40,17    70     59,83  117  40,34 
The results of the analysis in Table 1 can be seen, the percentage of events (died) 
was more in hemodialysis patients without comorbid non-cardiovascular disease 
(59.22%) compared to comorbid cardiovascular disease patients (40.78%). The mean 
age of patients in the comorbid cardiovascular disease group was 55.4(±15.3) years 
while the non-cardiovascular comorbid patients were 54.3(±11.4) years. Age category 
>60 years are more (46.34%) compared to age <60 years in patients undergoing 
hemodialysis in patients with comorbid cardiovascular disease (31.74%). There are 
more female patients (40.32%) compared to male ones in hemodialysis patients with 
comorbid cardiovascular disease (36.14%). Complications of anemia were more in 
patients undergoing hemodialysis with comorbid cardiovascular disease (40.23%) 
compared to patients without anemia (36.95%). Diabetes mellitus was more common in 
patients undergoing hemodialysis with comorbid cardiovascular disease (40.85%) 
compared to patients undergoing hemodialysis without diabetes mellitus (36.99%). 
Hypertension was more common in patients undergoing hemodialysis for comorbid 
cardiovascular disease (40.17%) than patients undergoing comorbid hemodialysis for 
cardiovascular disease without hypertension (36.42%). It appears that there are 
differences in characteristics between groups of patients undergoing hemodialysis with 
comorbid cardiovascular disease and non-comorbid cardiovascular disease. Therefore, it 
will be controlled in a multivariate analysis. 
Table 2. Average Survival of Patients Undergoing Hemodialysis at Friendship Hospital 
in 2015-2019. 
Patients undergoing hemodialysis Mean Min-Max 
Cardiovascular Disease Comorbid 32 months 1-78 month 
Comorbid Not Cardiovascular Disease 23 months 1-78 month 
The results of the analysis in Table 2 can be seen that the average survival of 
patients undergoing hemodialysis with comorbid cardiovascular disease is longer than 
patients without comorbid cardiovascular disease. The average survival of patients 
undergoing hemodialysis with comorbid cardiovascular disease was 32 months, while 
for non-comorbid cardiovascular disease was 23 months. 
Table 3. The relationship between independent variables and covariate variables on the 
survival of patients undergoing hemodialysis at Persahabatan Central Public Hospitalin 
2015-2019 using the Cox Regression Test. 
Variable HR 95%CI P-
Value 
Independent    
Cardiovascular Disease Comorbid 0,76 0,513 – 1,134 0,181 
 Not Cardiovascular Disease      1   
Covariate Variable    
Age    
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< 60 years 1,54 1,043 - 2,262 0,029 
 ≥ 60 years      1   
Gender    
Male 0,87 0,587 - 1,276 0,467 
Female      1   
Anemia    
Yes 0,68 1,117 - 2,515 0,013 
No       1   
Diabetes Mellitus    
Yes 2,71 1,780 - 4.11 0.000 
No       1   
The results of the bivariate analysis in table 3 above show that of the 5 variables, 
which are cardiovascular disease, age, hypertension, comorbid diabetes mellitus and 
anemia complications. There are 4 variables that have a significant risk for survival of 
patients undergoing hemodialysis with p <0.05. These variables include age, anemia, 
diabetes mellitus and hypertension. After selecting the confounding variables on the 
candidate variables, it was found that there was no change in HR in the independent 




Figure 1. Probability of Survival of Patients Undergoing Hemodialysis Based on 
Comorbid Cardiovascular Disease at Persahabatan Central Public Hospital 2015-2019.  
The curve in Figure1. showed that patients with comorbid cardiovascular disease 
were more likely to survive than non-cardiovascular comorbid patients. The results of 
the log rank test with p-value = 0.175 (>0.05) displayed that there was no statistically 
significant difference in the probability of survival between patients with cardiovascular 
comorbidities and no cardiovascular comorbidities. To describe the probability of 
survival of patients undergoing hemodialysis, a survival function with the life table 
method is used which can be seen in table 4. 
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Table 4. Life Table of Survival of Patients Undergoing Hemodialysis Based on 
Comorbid Cardiovascular Disease at Persahabatan Central Public Hospital 2015-2019 
Time (month) Cardiovascular Disease 
Comorbid (%) 
Not Comorbid Cardiovascular 
Disease (%) 
12 81.4 76.8 
24 73.3 67.3 
36 65.4 51.6 
48 56.6 49.8 
60 45.7 34.5 
Table 4 above shows that the probability of survival of hemodialysis patients is higher 
with comorbid cardiovascular disease compared to comorbid non-cardiovascular 
disease. In the first year or 12 months, 81.4% of comorbid cardiovascular disease 
patients were still alive, while 76.8% of HD patients were not comorbid with 
cardiovascular disease. Year 5- or 60-months survival of HD patients with comorbid 
cardiovascular disease is 45% while non-comorbid cardiovascular disease is 34.5%. 
Table 5. Final Model of Survival of Patients Undergoing Hemodialysis at Persahabatan 
Central Public Hospital in 2015-2019 using the Cox Regression Test 
Variable HR SE 95% CI P-Value 
Cardiovascular Disease 0,76 0,15 0,51-1,13 0,181 
Patients undergoing hemodialysis with comorbid cardiovascular disease will have 
a hazard of 0.76 times for death compared to patients with non-cardiovascular 
comorbidities. 
In this study, the average age of patients with kidney disease undergoing 
hemodialysis based on comorbid cardiovascular disease was 55.4 years in patients with 
comorbid cardiovascular disease. The mean age of patients older than the Msaad study 
(2019), is 44.3 years for comorbid cardiovascular disease patients. The age group of ≥60 
years is more than age <60 years. The age of the elderly based on the 2014 Minister of 
Health is someone who is 60 years old. Various studies regarding the low survival of 
patients undergoing hemodialysis state that older age is one of the most significant 
predictors of advanced age (Indonesian Renal Registry, 2018). In chronic kidney 
disease and some forms of acute renal failure, the GFR falls below the normal value of 
125 ml/min. GFR also decreases with age, after the age of 30, the GFR value decreases 
at a rate of about 1 ml/min (Price, & Wilson, 2005). With increasing age, physiological 
functions decrease due to the aging process so that non-communicable diseases appear 
in the elderly (Kementerian Kesehatan Republik Indonesia, 2016). The kidneys cannot 
regenerate new nephrons so that when there is kidney damage or the aging process, 
there is a decrease in the number of nephrons. At the age of 40, the number of 
functioning nephrons decreases by about 10% every 10 years, and at the age of 80 
years, only 40% of the nephrons are functioning (Siagian, & Damayanty, 2018). 
Female gender was higher than male patients, namely 40.32%. This is in line with 
research conducted by Msaad, that patients undergoing hemodialysis both with 
comorbid cardiovascular disease and non-comorbid cardiovascular disease with female 
sex as much as 54.4%, while patients with male gender 40% (Msaad, et al., 2019). This 
study is also in line with research conducted by Sikole A which states that women 
survive more than men (Sikole, et al., 2007). This study is not the same as the research 
conducted by IRR (Indonesian Renal Registry) in 2016 which explained that there were 
more males than females. 
The results of this study indicate that patients who experience anemia while 
undergoing hemodialysis are higher in patients with comorbid cardiovascular disease 
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(40.23%) compared to non-cardiovascular comorbidities (36.95%). Anemia is the most 
common abnormality in patients with decreased kidney function followed by a decrease 
in hemoglobin or hematocrit. Hence, the routine hematological examination of patients 
is important whether there is anemia. More than 85% of patients with chronic kidney 
disease (CKD), particularly in the advanced stages will experience anemia. Mortality of 
Chronic Kidney Disease (CKD) will be higher if accompanied by anemia (Syam, 2013). 
The results of this study indicate that patients with comorbid diabetes mellitus 
while undergoing hemodialysis are higher in patients with comorbid cardiovascular 
disease (40.85%) compared to non-cardiovascular comorbidities (36.99%). 
In this study, the survival probabilities of 1 year, 2 years, 3 years, 4 years and 5 
years of patients undergoing hemodialysis with comorbid cardiovascular disease were 
81.4%, 73.3%, 65.4%, 56.6% and 45.7% while non-cardiovascular comorbidities were 
76.8%, 67.3%, 51.6%, 49.8% and 34.5%. From these results, it can be seen that the 
probability of survival of patients undergoing hemodialysis with comorbid 
cardiovascular disease is higher than that of non-cardiovascular comorbidities. It is in 
accordance with research conducted by Mardhatillah, which states that the 1-year 
survival of chronic kidney failure patients undergoing hemodialysis is 82% each 
(Mardhatillah, 2020). 
Furthermore, based on survival time, patients undergoing hemodialysis with 
comorbid cardiovascular disease have a longer mean time to death, which is 32 months 
compared to patients with non-cardiovascular comorbidities. The results of this study 
are lower than the research conducted at Soetomo Public Hospital which states that 
patients undergoing hemodialysis are generally 67.84 months old (Yulianto, & Basuki, 
2017). 
The risk of survival of patients undergoing hemodialysis based on comorbid 
cardiovascular disease in this study was bivariate and multivariate, the HR value was 
0.762 (95% CI 0.513 - 1.134). This is not in accordance with a study conducted in 
Morocco, that cardiovascular disease can increase 2.9 (95% CI 1.33-7.0) times the 
occurrence of death in hemodialysis patients compared to patients without comorbid 
cardiovascular disease (Msaad, et al., 2019). The results of this study are also not in line 
with research in the United States, that cardiovascular disease can increase 1.31 times 
the occurrence of death in hemodialysis patients compared to patients without comorbid 
cardiovascular disease after controlling for age, gender, race, age at first kidney failure, 
and comorbidities that others (Modi, et al., 2019). This is due to the high loss to follow 
in both groups (comorbid cardiovascular disease group with non-cardiovascular 
disease). 
Although cardiovascular disease is the most common cause of death in chronic 
kidney disease (CKD) patients undergoing HD, Jager et al. in 2009 reached a different 
conclusion. In her study, chronic kidney disease (CKD) patients who started HD had a 
higher risk of death than the general population but was not specifically caused by 
cardiovascular disease (Umami, et al., 2017). Death in patients with chronic kidney 
disease (CKD) was 39% with cardiovascular disease and 51% were non-cardiovascular. 
In the general population, 40% of deaths are cardiovascular and 58% are non-
cardiovascular diseases (De Jager, et al., 2009). 
Retrieval of data from the hospital information system has several advantages, 
especially efficiency in terms of time, cost and some field resources. However, it also 
has limitations related to the observed factors because it must be adjusted to the 
availability of data which then results in limited determination of variables. Lost to 
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follow-up in this study was 36.2%, because this lost to follow was more than 20%. 
Therefore, in this study, there is a selection bias that can affect internal validity. This 
study employed secondary data so that researchers have not been able to control the 
quality at the data collection stage. Therefore, researchers have not been able to control 
the possible bias. 
4. CONCLUSION 
Patients undergoing hemodialysis with comorbid cardiovascular disease have a 
risk of death of 0.76 times compared to patients undergoing hemodialysis with the 
comorbid non-cardiovascular disease. However, the results of this study are influenced 
by selection bias and non-differential misclassification information bias. Thus, the 
results of this study cannot be generalized. It is hoped that this study can be developed 
further by examining the survival of patients undergoing hemodialysis with other 
variables such as comorbid protein-energy malnutrition, hepatitis, and others. 
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